Growth Metrics

Trulieve Cannabis (TCNNF) Cost of Revenue (2020 - 2026)

Trulieve Cannabis has reported Cost of Revenue over the past 6 years, most recently at $118.0 million for Q4 2025.

  • For Q4 2025, Cost of Revenue rose 3.38% year-over-year to $118.0 million; the TTM value through Dec 2025 reached $470.0 million, changed 0.16%, while the annual FY2025 figure was $470.0 million, 0.16% changed from the prior year.
  • Cost of Revenue for Q4 2025 was $118.0 million at Trulieve Cannabis, roughly flat from $118.3 million in the prior quarter.
  • Over five years, Cost of Revenue peaked at $359.4 million in Q4 2023 and troughed at $44.6 million in Q1 2021.
  • A 5-year average of $109.8 million and a median of $114.3 million in 2024 define the central range for Cost of Revenue.
  • Biggest five-year swings in Cost of Revenue: soared 520.84% in 2023 and later plummeted 68.24% in 2024.
  • Year by year, Cost of Revenue stood at $69.0 million in 2021, then decreased by 16.17% to $57.9 million in 2022, then soared by 520.84% to $359.4 million in 2023, then plummeted by 68.24% to $114.1 million in 2024, then grew by 3.38% to $118.0 million in 2025.
  • Business Quant data shows Cost of Revenue for TCNNF at $118.0 million in Q4 2025, $118.3 million in Q3 2025, and $119.2 million in Q2 2025.